
Is It Time to Rethink STEMI and NSTEMI Classification? - Medscape
Feb 4, 2025 · The conventional classification of acute myocardial infarction (AMI) into ST-segment elevation (STEMI) and non-ST-segment elevation (NSTEMI) has long guided clinical decision …
Does STEMI Need a Rebrand to ‘Occlusion MI’? - Medscape
Dec 10, 2024 · A review paper prompted a discussion among cardiologists Bob Harrington, Manesh Patel, and Michael Gibson on whether the ST-segment elevation myocardial infarction paradigm …
Novel Stent Promises to Reduce Long-Term Failure - Medscape
These differences between 6 and 12 months were highly consistent across subgroups defined by age, sex, comorbidities, type of acute coronary syndrome (STEMI vs NSTEMI) and lesion characteristics ...
Antithrombotic Therapy in ACS: From STEMI Presentation to Follow-up ...
Email This IN THIS PROGRAM: Case Index Go to Test Questions » Presentation of ACS Case Presentation Fibrinolysis vs PCI Adjunctive Therapy Intervention
New ESC ACS Guideline Combines STEMI and NSTE-ACS - Medscape
Sep 8, 2023 · The guideline task force says STEMI and non-ST elevation ACS represent a spectrum, and after the initial triage and management decisions, most of the remaining care follows a common …
Low-Molecular-Weight Heparin for Acute STEMI - Medscape
It is divided into acute ST-segment elevation myocardial infarction (STEMI) and acute non-ST-segment elevation myocardial infarction (NSTEMI), of which STEMI has the higher mortality rate. [1]
Top Updates in 2025 ACS Management Guidelines - Medscape
Jun 30, 2025 · Dr Amal Mattu breaks down the key updates — and lingering pitfalls — in the 2025 ACS guidelines that every acute care clinician should know.
Optimal Aspirin Dose in Acute Coronary Syndromes - Page 5
What the Guidelines for ACS Recommend Prior ACS guidelines recommended moderate-to-high dose aspirin (162–325 mg) for at least 1 month after ACS and stent implantation (Box 1). [27, 28] However ...
MI–Atrial Fibrillation Link May Apply Most to NSTEMI ... - Medscape
Apr 27, 2015 · The investigators write that the culprit artery is totally occluded by a thrombus in STEMI vs being "patent with a nonocclusive thrombus" in NSTEMI.
RIVAL: Radial PCI benefits in STEMI - Medscape
Oct 26, 2012 · Further analysis of the RIVAL trial has shown impressive reductions in key end points, including all-cause mortality, with the radial approach in patients with STEMI vs non-STEMI patients …